Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 15 studies | 31% ± 11% | |
glutamatergic neuron | 9 studies | 38% ± 21% | |
GABAergic neuron | 8 studies | 33% ± 18% | |
oligodendrocyte precursor cell | 8 studies | 27% ± 10% | |
neuron | 7 studies | 35% ± 13% | |
astrocyte | 5 studies | 20% ± 4% | |
interneuron | 5 studies | 32% ± 16% | |
endothelial cell | 4 studies | 31% ± 9% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
retinal ganglion cell | 3 studies | 59% ± 22% | |
fibroblast | 3 studies | 20% ± 4% | |
ciliated cell | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 31% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 17189.97 | 2642 / 2642 | 100% | 136.90 | 705 / 705 |
thymus | 99% | 3442.35 | 648 / 653 | 99% | 30.82 | 598 / 605 |
kidney | 100% | 3486.26 | 89 / 89 | 98% | 29.57 | 880 / 901 |
prostate | 100% | 4400.31 | 244 / 245 | 98% | 22.99 | 491 / 502 |
adrenal gland | 99% | 3399.90 | 255 / 258 | 95% | 54.26 | 219 / 230 |
breast | 100% | 3027.41 | 457 / 459 | 87% | 17.31 | 970 / 1118 |
skin | 83% | 1722.60 | 1503 / 1809 | 96% | 31.87 | 451 / 472 |
ovary | 100% | 5979.52 | 180 / 180 | 74% | 10.77 | 318 / 430 |
lung | 99% | 3707.20 | 573 / 578 | 67% | 10.09 | 773 / 1155 |
uterus | 99% | 7356.94 | 168 / 170 | 50% | 12.49 | 228 / 459 |
bladder | 100% | 4844.05 | 21 / 21 | 40% | 6.23 | 203 / 504 |
pancreas | 37% | 669.61 | 122 / 328 | 91% | 25.05 | 162 / 178 |
esophagus | 77% | 4475.06 | 1111 / 1445 | 43% | 5.31 | 78 / 183 |
intestine | 86% | 4622.23 | 834 / 966 | 32% | 4.23 | 168 / 527 |
stomach | 68% | 2398.17 | 243 / 359 | 40% | 5.63 | 115 / 286 |
eye | 0% | 0 | 0 / 0 | 100% | 36.14 | 80 / 80 |
blood vessel | 100% | 5146.60 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 3147.31 | 791 / 803 | 0% | 0 | 0 / 0 |
spleen | 98% | 2505.03 | 237 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 2818.09 | 1179 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 4706.68 | 825 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 13.84 | 24 / 29 |
liver | 0% | 8.17 | 1 / 226 | 50% | 6.56 | 205 / 406 |
tonsil | 0% | 0 | 0 / 0 | 36% | 4.89 | 16 / 45 |
peripheral blood | 19% | 373.40 | 179 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0006939 | Biological process | smooth muscle contraction |
GO_1902807 | Biological process | negative regulation of cell cycle G1/S phase transition |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0007165 | Biological process | signal transduction |
GO_0006974 | Biological process | DNA damage response |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007409 | Biological process | axonogenesis |
GO_0050714 | Biological process | positive regulation of protein secretion |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006915 | Biological process | apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0045202 | Cellular component | synapse |
GO_0030426 | Cellular component | growth cone |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0070064 | Molecular function | proline-rich region binding |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0050750 | Molecular function | low-density lipoprotein particle receptor binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | APBB1 |
Protein name | Adaptor protein FE65a2 Amyloid beta precursor protein binding family B member 1 (Amyloid-beta A4 precursor protein-binding family B member 1) (Protein Fe65) Amyloid beta precursor protein binding family B member 1 |
Synonyms | RIR FE65 |
Description | FUNCTION: Transcription coregulator that can have both coactivator and corepressor functions . Adapter protein that forms a transcriptionally active complex with the gamma-secretase-derived amyloid precursor protein (APP) intracellular domain . Plays a central role in the response to DNA damage by translocating to the nucleus and inducing apoptosis . May act by specifically recognizing and binding histone H2AX phosphorylated on 'Tyr-142' (H2AXY142ph) at double-strand breaks (DSBs), recruiting other pro-apoptosis factors such as MAPK8/JNK1 . Required for histone H4 acetylation at double-strand breaks (DSBs) . Its ability to specifically bind modified histones and chromatin modifying enzymes such as KAT5/TIP60, probably explains its transcription activation activity . Functions in association with TSHZ3, SET and HDAC factors as a transcriptional repressor, that inhibits the expression of CASP4 . Associates with chromatin in a region surrounding the CASP4 transcriptional start site(s) . Involved in hippocampal neurite branching and neuromuscular junction formation, as a result plays a role in spatial memory functioning (By similarity). Plays a role in the maintenance of lens transparency (By similarity). May play a role in muscle cell strength (By similarity). Acts as a molecular adapter that functions in neurite outgrowth by activating the RAC1-ARF6 axis upon insulin treatment . . |
Accessions | ENST00000609360.6 [O00213-1] ENST00000608655.6 [O00213-5] ENST00000299402.10 [O00213-2] ENST00000529890.5 ENST00000530885.5 [O00213-3] ENST00000608394.5 [O00213-4] V9GY97 ENST00000608645.5 [O00213-4] ENST00000529519.5 ENST00000609331.5 [O00213-6] A0A075B7G8 ENST00000608435.5 ENST00000608704.5 [O00213-4] ENST00000311051.7 [O00213-2] V9GYR7 O00213 Q8TEY4 ENST00000532020.2 V9GYD5 |